Ethical practice in private healthcare investment
The healthcare sector has seen consistent global growth over the past decade, positioning itself as an increasingly attractive destination for private capital investment.
But while private capital has been flooding into healthcare, it has raised some difficult questions. Can you really put patients first while chasing profits? And does private investment actually improve care, or does it risk making it worse? There are debates murmuring around the fringes of privately funded healthcare.
Some critics have expressed concern that chasing quick profits can put patient care at risk. Providers may cut corners when the pressure to deliver returns arises. Reducing staff, limiting services or employing aggressive pricing strategies can be a method to meet financial targets.
There have been questions about the quality of care and transparency. For example, UK private mental health provider Priory Group has faced several investigations after patient deaths and inconsistent care planning, with inspection reports not always made public. On the other side of the world, Australian whistleblowers have alleged that some fertility clinics have prioritised maximising cycle numbers over patient wellbeing, while withholding clear success-rate data from prospective patients.
With governments and the media paying closer attention, it highlights just how crucial it is to build trust and for the private healthcare market to keep patient well-being at the core.
In spite of these criticisms, private investment in healthcare has proven to be a powerful force for good. Providers now have increasingly improved access to resources they need in order to offer better services, especially in underdeveloped regions which haven’t always had easy access to care. In many cases, private investment has directly brought new services to communities that need them.
The onus is now on investors to be mindful of how care is delivered, not just how much revenue it generates. Across the board, standards are being raised due to a growing focus on models that reward better patient outcomes. Many investors and providers are building ESG frameworks into their strategies from the outset, and have ultimately set up their strategies to maximise patient health and happiness, in conjunction with profitability. Nowadays, It can be seen that some of the most trusted and high-quality providers have backing from private equity, proving that private investment can support a care system that works for everyone.
Finding the right balance between earning returns and genuinely making a positive impact is now the standard in private healthcare investing. Examples such as Fresenius and Bupa have proven that it’s possible to build successful businesses while keeping care and strong ethical values at the fore. Increasingly, investors who succeed will be those who support high-quality care and take a considered approach to expanding and improving healthcare services for everyone.
Private investment will continue to be a catalyst for progress in the healthcare market, provided the right vision, governance and commitment is present. Investors must act as the flag-bearers for empowering innovation and delivering effective care to more people than ever before. Healthcare is growing, and responsible investors are in the position to not just shape the market, but to set new standards for a healthier, more equitable future.
We would welcome your thoughts on this story. Email your views to Oscar Faulkner or call 0207 183 3779.
